UPDATE 2-U.S. court rules for Teva in migraine patent dispute with Eli Lilly
March 31, 2020 at 14:02 PM EDT
Teva Pharmaceutical Industries Ltd on Tuesday won a ruling from a U.S. administrative court that could help it fend off competition from Eli Lilly and Co in the market for migraine drugs.